Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 23, 2016

M&As this week: Guangdong Biolight Meditech, Royal Philips, Paramit Corporation

Guangdong Biolight Meditech has announced that it will acquire a 20% stake in a minimally-invasive medical device company based in Changzhou.

Guangdong Biolight Meditech has announced that it will acquire a 20% stake in a minimally-invasive medical device company based in Changzhou.

The acquisition is expected to cost CNY20m ($3.04m).

Kunming Longjin Pharmaceutical, manufacturer of natural botanical and chemical freeze-dried medicines based in China, has agreed to sell its pharmaceutical technology development subsidiary based in Beijing for CNY2m ($0.3m).

Royal Philips has completed the acquisition of PathXL from Queen’s University.

"By acquiring PathXL, Royal Philips will be able to expand its digital pathology solutions portfolio."

By acquiring PathXL, a digital pathology workflow solutions provider, Royal Philips will be able to expand its digital pathology solutions portfolio.

Paramit Corporation has completed the acquisition of Lathrop Engineering, whose design centre in San Jose, California, will be handed over to the former following the transaction.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The acquisition allows Paramit to further improve its design and manufacturing capabilities of complex medical and life sciences instruments.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU